Insider NameBuy/SellCompany NameTickerAmountShares Change
May 28, 2025Jun 16, 2025Leonard Braden Michael
10%
SellAn2 Therapeutics, Inc.ANTX$1.09$218,000-6.22%
May 28, 2025May 30, 2025Leonard Braden Michael
10%
SellAn2 Therapeutics, Inc.ANTX$1.13$3M-44.04%
Mar 26, 2025Apr 28, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$5.11$188,931+1.28%
Mar 26, 2025Apr 28, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$5.11$188,931+1.28%
Apr 22, 2025Apr 24, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$3$1M+9.72%
Mar 31, 2025Apr 02, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$4.23$147,076+0.61%
Mar 26, 2025Mar 27, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$5.11$188,931+1.28%
Mar 18, 2025Mar 21, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$4.98$587,575+2.09%
Feb 26, 2025Feb 28, 2025Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$4.27$1M+11.05%
Sep 24, 2024Sep 26, 2024Leonard Braden Michael
10%
BuyReneo Pharmaceuticals, Inc.RPHM$1.47$144,738+2.15%
Sep 17, 2024Sep 19, 2024Leonard Braden Michael
10%
BuyReneo Pharmaceuticals, Inc.RPHM$1.36$76,237+1.26%
Sep 12, 2024Sep 16, 2024Leonard Braden Michael
10%
BuyReneo Pharmaceuticals, Inc.RPHM$1.35$484,344+7.66%
Sep 05, 2024Sep 09, 2024Leonard Braden Michael
10%
BuyTalis Biomedical CorpTLIS$1.47$44,240+10.80%
Sep 03, 2024Sep 05, 2024Leonard Braden Michael
10%
BuyTalis Biomedical CorpTLIS$4$2,000+0.23%
Aug 30, 2024Sep 05, 2024Leonard Braden Michael
10%
BuyTalis Biomedical CorpTLIS$4.25$642+0.07%
Aug 26, 2024Aug 28, 2024Leonard Braden Michael
10%
BuyTalis Biomedical CorpTLIS$3.9$56,137+6.19%
Aug 13, 2024Aug 15, 2024Leonard Braden Michael
10%
BuyReneo Pharmaceuticals, Inc.RPHM$1.4$380,598+6.42%
Aug 14, 2024Aug 15, 2024Leonard Braden Michael
10%
BuyAn2 Therapeutics, Inc.ANTX$1.04$2M+20.69%
Aug 02, 2024Aug 05, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.27$472,757+1.30%
Jul 30, 2024Jul 31, 2024Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$7.15$613,470+3.49%
Jul 30, 2024Jul 31, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.31$359,010+0.98%
Jul 18, 2024Jul 22, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.3$201,808+0.57%
Jul 17, 2024Jul 19, 2024Leonard Braden Michael
10%
BuyAdverum Biotechnologies, Inc.ADVM$8.26$2M+8.64%
Jul 02, 2024Jul 05, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.15$405,894+1.31%
Jun 27, 2024Jul 01, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.13$2M+5.84%
Jun 14, 2024Jun 18, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.15$628,206+2.32%
Jun 11, 2024Jun 13, 2024Leonard Braden Michael
10%
BuyAclaris Therapeutics, Inc.ACRS$1.11$2M+12.77%
May 14, 2024May 16, 2024Leonard Braden Michael
10%
BuyReneo Pharmaceuticals, Inc.RPHM$1.54$639,578+10.09%
May 13, 2024May 15, 2024Leonard Braden Michael
10%
BuyAvrobio, Inc.AVRO$1.27$971,493+12.92%
Mar 20, 2024Mar 25, 2024Leonard Braden Michael
10%
BuyCyteir Therapeutics, Inc.CYT$2.95$503,238+4.10%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.